Left ventricular myocardial dysfunction in young and middle-aged ischemic stroke patients: the Norwegian stroke in

Sahrai Saeed1, Eva Gerdts1,2, Ulrike Waje-Andreassen3

  • 1Department of Heart Disease, Haukeland University Hospital.

Journal of Hypertension
|September 7, 2018
PubMed

Insights

Hypertension in ischemic stroke patients is linked to reduced global longitudinal strain (GLS), indicating subclinical left ventricular dysfunction. This association persists even after accounting for other risk factors.

Area of Science:

  • Cardiology
  • Neurology
  • Echocardiography

Background:

  • Hypertension is common in patients with ischemic stroke.
  • The impact of hypertension on subclinical left ventricular (LV) dysfunction in these patients is not well understood.
  • Left ventricular myocardial dysfunction can be assessed using echocardiography.

Purpose of the Study:

  • To investigate the association between hypertension and subclinical left ventricular (LV) dysfunction in ischemic stroke patients.
  • To assess the impact of hypertension on global longitudinal strain (GLS) and global circumferential strain (GCS).

Main Methods:

  • 276 ischemic stroke patients (15-60 years) underwent conventional and speckle tracking echocardiography.
  • Hypertension was defined by medical history, medication use, or elevated blood pressure measurements.
  • Subclinical LV dysfunction was evaluated using peak systolic global longitudinal strain (GLS) and global circumferential strain (GCS).

Main Results:

  • 68% of patients had hypertension, associated with higher age, BMI, LV mass, male sex, and diabetes.
  • Hypertensive patients showed significantly lower GLS and GCS compared to normotensive patients.
  • Reduced GLS remained significantly associated with hypertension after adjusting for confounders, while GCS association was attenuated.

Conclusions:

  • In ischemic stroke survivors, hypertension is independently associated with reduced peak systolic global longitudinal strain (GLS).
  • This suggests hypertension contributes to subclinical left ventricular dysfunction in ischemic stroke patients.
  • The association with global circumferential strain (GCS) was not independent of other factors.
Abstract

Related Concept Videos

Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
5.2K
Cardiac Output and Stroke Volume01:11

Cardiac Output and Stroke Volume

Cardiac output (CO) is an integral aspect of human physiology, reflecting the heart's efficiency and responsiveness to the body's needs. It represents the volume of blood that the left or right ventricle ejects into the aorta or pulmonary trunk each minute. The CO is calculated by multiplying the heart rate (HR)—the number of heartbeats per minute—by the stroke volume (SV)—the amount of blood pumped out with each heartbeat.
In an average resting adult male, the typical cardiac...
4.9K
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
3.4K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
239
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
704
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
262